VCP
IDXX icon

Verus Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Verus Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$12K Buy
+50
New +$13K ﹤0.01% 945

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Verus Capital Partners's IDXX Position: Q1 2020 in Review

Verus Capital Partners opened a new position in Idexx Laboratories (IDXX) in Q1 2020: 50 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #945 among its holdings.

748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Verus Capital Partners held 50 shares of Idexx Laboratories worth $12K as of Q1 2020.
  • Idexx Laboratories was a new Verus Capital Partners position in Q1 2020.
  • Idexx Laboratories made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #945 holding.
  • 748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.